Tuesday, March 24, 2026

Big Pharma Braces for $300 Billion Loss as Blockbuster Drug Patents Expire

Global pharma faces $300B losses from patent expirations, prompting a shift to multi-indication drugs and innovative therapies.

Kim Unveils “Hwasong-20” ICBM as China and Russia’s Top Officials Attend North Korea’s Anniversary Parade

Kim Jong Un showcased the new Hwasong-20 ICBM at the Workers' Party anniversary, emphasizing North Korea's nuclear status and alliances.

MERCYLESS SEOUL: Former UNSG Publicly Condemns South Korea For Ignoring Basic Human Rights

Ban Ki Moon highlights the Lee administration's support for North Korean human rights at the UN, calling for consistent policies amid political shifts.

Tag: Rasmotinib

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

How Rasmotinib and PHI-501 Could Revolutionize Cancer Treatment: Insights from Bio Europe Spring 2026

Pharos iBio showcases its cancer treatments at Bio Europe Spring 2026, seeking global partnerships for Rasmotinib and PHI-501.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.